Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
ImmunoTargets and Therapy · 2025-04 · Volume 14 · 339-357
DOI: 10.2147/itt.s495751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ImmunoTargets and Therapy, 2025-04. Verfasst von Chiara Corti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
- Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
- Division of Breast Surgery, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
ORCID-Profile: Chiara Corti, Beyza Koca, Tasnim Rahman, Elizabeth A Mittendorf, Sara M Tolaney
Zitieren
APA
Corti, C., Koca, B., Rahman, T., Mittendorf, E. A., & Tolaney, S. M. (2025). Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer. ImmunoTargets and Therapy, Volume 14, 339-357. https://doi.org/10.2147/itt.s495751
Vancouver
Corti C, Koca B, Rahman T, Mittendorf EA, Tolaney SM. Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer. ImmunoTargets and Therapy. 2025;Volume 14:339-357. doi:10.2147/itt.s495751
BibTeX
@article{Corti2025,
author = {Corti, Chiara and Koca, Beyza and Rahman, Tasnim and Mittendorf, Elizabeth A and Tolaney, Sara M},
title = {Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer},
journal = {ImmunoTargets and Therapy},
year = {2025},
volume = {Volume 14},
pages = {339--357},
doi = {10.2147/itt.s495751}
}
EUVIMED